SUMO pathway inhibition targets an aggressive pancreatic cancer subtypeAlexander Biederstädt, Ulrich Keller, Christian Schneeweis et al.|Gut|2020Cited by 100
MYC and EGR1 synergize to trigger tumor cell death by controlling NOXA and BIM transcription upon treatment with the proteasome inhibitor bortezomibMatthias Wirth, Günter Schneider|Nucleic Acids Research|2014Cited by 64
Targeting the ubiquitin‐proteasome system in a pancreatic cancer subtype with hyperactive MYCKatharina Lankes, Matthias Wirth|Molecular Oncology|2020Cited by 23
Targeting Mutual Dependence of Phosphatidylinositol-3-Kinase α/δ and Small Ubiquitin-Like Modifier Signaling in Pancreatic CancerHazal Köse, Matthias Wirth|Gastroenterology|2025Cited by 2
Acetylation-dependent control of SIAH2 links JAK2V617F to mitochondrial respiration and ROS-associated apoptosisOliver H. Krämer, Matthias Wirth|Research Square|2024Cited by 0